Therapeutic angiogenesis: a step forward in intermittent claudication
- 1 June 2002
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 359 (9323) , 2048-2050
- https://doi.org/10.1016/s0140-6736(02)08946-8
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Augmentation of Postnatal Neovascularization With Autologous Bone Marrow TransplantationCirculation, 2001
- Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation studyJournal of the American College of Cardiology, 2000
- Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trialJournal of the American College of Cardiology, 2000
- Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogsJournal of the American College of Cardiology, 2000
- Effect of Intracoronary Recombinant Human Vascular Endothelial Growth Factor on Myocardial PerfusionCirculation, 2000
- Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb IschemiaCirculation, 1998
- Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution.Cardiovascular Research, 1997
- Basic Fibroblast Growth Factor Increases Collateral Blood Flow in Rats With Femoral Arterial LigationCirculation Research, 1996
- Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injuryMolecular and Cellular Biochemistry, 1995
- Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperativityBiochemistry, 1992